Thyroid cancers, like hematological malignancies, are commonly associated with chromosomal translocations leading to the formation of fusion proteins. Through altered signaling by fusion proteins, cell death and survival pathways are disrupted and the physiological balance of cell-cell communication may be lost. A consequence of this disruption is the release of factors by stressed cells that alert the host. One type of host response is leukocytic infiltration that may develop into chronic inflammation or autoimmune disease. Although inflammation can be associated with neoplastic tissue, the mechanism driving this process is largely unknown. Therefore, to address the mechanism of cancer inflammation we investigated the effects of an oncogene in a murine model system. A comprehensive genetic analysis revealed several soluble factors that were induced by RET/papillary thyroid carcinoma (PTC)3 gene expression including several proinflammatory cytokines, chemokines and immunologically relevant costimulatory molecules. Following a large genetic screen using RP3-expressing thyroid cells, we identified a highly abundant transcript and later identified it as interleukin 24 (Il24), a cytokine with diverse tumor suppressor and inflammatory activities. We show that RET/PTC3 induces Il24 expression in rat thyrocytes and that this expression is dependent on the signaling properties of its tyrosine kinase. Likewise, RET/PTC3 induces large amounts of Il24 following expression in murine thyrocytes, but its expression is dramatically reduced in poorly differentiated carcinomas, a finding that parallels the loss of RET/PTC3 expression. Consistent with its behavior as a tumor suppressor, the loss of Il24 coincided with the loss of RET/PTC3 in poorly differentiated mouse tumors. A functional role of Il24 in the autocrine growth/survival of RET/PTC3-expressing thyroid cells was identified helping to support its role in cellular transformation. These data suggest that the induction of Il24 by oncogenes may support tumor growth at the early stages of cancer.
Introduction
The development of thyroid cancer, like other malignancies, can be associated with inflammation or autoimmune disease. Consistent with this notion, 10-40% of patients diagnosed with Hashimoto's thyroiditis (HT) may show evidence of concurrent thyroid carcinoma (Dailey et al., 1955; Ott et al., 1987) . Although the role of these immune infiltrates is uncertain, clinical studies have shown that patients with papillary thyroid carcinoma (PTC) that present with thyroiditis (PTC/ HT) have a better clinical outcome than patients diagnosed with PTC alone (Matsubayashi et al., 1995; Loh et al., 1999; Tamimi, 2002) . Understanding the molecular mechanisms that distinguish PTC from PTC/ HT will be critical if we are to take advantage of the anticancer responses that likely explain the difference between these two pathologies. Along these lines, some information about the early stages of cancer may provide important clues about this difference. RET/ PTC oncogenes are a family of fusion proteins derived from chromosomal rearrangements involving the tyrosine kinase domain of the c-RET proto-oncogene and are frequent mutations found early in the development of a variety of differentiated thyroid carcinomas (Jhiang et al., 1992; Santoro et al., 1992; Fusco et al., 1995; Takahashi et al., 1995; Fugazzola et al., 1996; Sugg et al., 1996; Bongarzone et al., 1997) . Whereas RET/PTC expression has been frequently observed in patients affected with PTCs showing concurrent thyroiditis, its expression was also reported in thyroid tissue of patients afflicted with HT with no detectable cancer suggesting a common etiology of these two diseases (Wirtschafter et al., 1997; Sheils et al., 2000; Mechler et al., 2001; Pasquale et al., 2001) . The association of RET/PTC with HT suggested that oncoproteins may be one component involved in promoting organ-specific inflammation. While the mechanism of how RET/PTC contributes to autoimmune thyroiditis is not clear, the activated tyrosine kinase activity associated with RET/PTC has been shown to support the production of inflammatory mediators and induce inflammation (Russell et al., 2003) . One member of this oncoprotein family RP3 (RP3) can induce nuclear NF-kB activity and the downstream effects of this activation including the production of the Gmcsf and Mcp1 from thyroid cells in vitro and in vivo (Russell et al., 2003 (Russell et al., , 2004 . Furthermore, cytokine synthesis was largely dependent on a tyrosine at position 588 of RET/PTC, which corresponds to tyrosine 1062 of c-RET, a Shc docking site critical for downstream signaling (Russell et al., 2003) .
To identify other inflammatory proteins requiring Shc-dependent signaling, we screened mRNAs from RET/PTC-expressing thyroid cells that were absent from cells expressing RP3 Tyr
588
. This analysis revealed additional factors induced by RP3 Tyr 588 including cytokines, chemokines and costimulatory molecules of immunological significance. Among these genes, we were especially interested in interleukin 24 (Il24), a member of the IL-10 gene family produced in abundance in RP3-expressing cells. Previous studies have shown that Il24 behaves like a tumor suppressor gene, although little was known about its role in the host response to cancer.
Il24 was originally identified as an abundant tumorspecific transcript expressed by human melanoma cells treated with interferonb (IFNb) and the protein kinase C activator mezerein (Jiang et al., 1995) . However, unlike its expression in normal melanocytes and benign lesions (nevi), advanced and metastatic melanomas lack detectable Il24 expression (Ekmekcioglu et al., 2001) . Interestingly, forced expression of Il24 using a recombinant adenovirus causes growth inhibition and apoptosis in a diversity of human cancers, but normal cells are unaffected (Su et al., 1998; Saeki et al., 2000; Ekmekcioglu et al., 2001; Lebedeva et al., 2003; Yacoub et al., 2003b) . This interesting distinction prompted the development of several clinical trials for the treatment of cancer. However, while clinical trials involving the use of Il24 as an cancer therapeutic are ongoing, little is known about its biological function in spontaneous disease (Sarkar et al., 2002; Fisher et al., 2003) . With regard to its function in the immune system, Il24 was shown to act as an antagonist of IL10 and induce the production of various proinflammatory mediators such as TNFa, IFNg, IL6, IL1b, IL12 and GMCSF through the binding of the heterodimeric receptors, IL20R1/ Il20R2 or IL22R1/ Il20R2 (Caudell et al., 2002; Wang et al., 2002) . Although a direct role of Il24 signaling in carcinogenesis has not been shown, indirect effects have been implied following the activation of oncogenic RAS that can induce Il24 in animal models (Zhang et al., 2000) .
To gain a better understanding of the role of soluble mediators at the early stages of cellular transformation, we investigated the role of the RP3 oncogene to induce I124 in thyroid cells in culture and from thyroids of RP3 transgenic mice. Moreover, using these in vitro and in vivo models, we assessed the function of Il24 on transformed thyroid cells and find a role for this tumor cell mediator in the growth of transformed cells.
Results

RP3 oncogene expression induces Il24 in thyroid cells
In empirical studies evaluating the role of the thyroid oncoprotein RP3 to alter cell survival pathways, we found several inflammatory factors produced from oncogene-expressing transfectants that were absent from mutant or control cells (Russell et al., 2003) . To extend these studies and to objectively identify additional factors that are produced following oncoprotein expression, we compared parental PC CL3 thyroid cells and those expressing RP3 or the Shc signaling mutant RP3 Y588F using a rat gene array containing 10 000 cDNAs. The function of RET/PTC1 to signal mitogenesis is dependent on the phosphorylation of tyrosine 451 and the subsequent binding of the adaptor protein Shc (Chiariello et al., 1998; Salvatore et al., 2000) . In our previous report, tyrosine 588 in RP3 corresponding to Tyr 451 in RET/PTC1 was required for the production of certain inflammatory cytokines including Gmcsf, Mcp1 and Kc/Groa (Russell et al., 2003) . Comparing the list of genes activated by RP3, but not by RP3 Y588F or vector controls, revealed the identity of several additional candidate genes whose function includes the induction of inflammation. For these studies, we focused on the expression of RP3-induced genes that showed a 10-fold or greater induction compared with controls (Table 1) . One mediator that showed a dramatic induction following RP3 expression was the inflammatory cytokine Il24. Il24 was induced 80-fold in RP3-expressing cells compared to vector controls. Il24, like many Gene identified by differential binding for a fluorescent cDNA probe onto a glass microarry chip containing 10 000 gene-specific rat oligonucleotides. Sequence information was obtained from the NCBI database and genes in gray were verified by RT-PCR in other studies (Russell et al., 2003) . b Ratio of hybridization signal for the listed gene in cells expressing RP3 versus cells transfected with vector alone. Number reflects the fold increase in gene expression RET/PTC3 oncoprotein induces Il24 S Shinohara and JL Rothstein mediators induced by RP3, was severely reduced or absent when analysed using the RP3 Y588F mutant, suggesting that this docking site was important for cytokine signaling (Russell et al., 2003) . An exception to this was Mcp1 and Kc/Groa that showed higher levels of gene transcription in RP3
Y588F -mutated cells when compared with vector control containing thyroid cells (23-and 10-fold, respectively, not shown), although still not as high as that observed in RP3-expressing cells. To confirm the Il24 gene array data, we performed RT-PCR. Although the expression of Il24 was significantly higher in RP3-expressing cells than that in vector controls, detectable levels of Il24 were also found in RP3 Y588F -expressing cells, consistent with the gene array data (Figure 1a and b). This induction was observed despite the expression of equal amounts of RP3 or mutant RP3 mRNA ( Figure 1a ) or protein (not shown). The production of Il24 protein synthesized by thyroid cells was verified by Western blot analysis ( Figure 1c ). The observed molecular weight of rat Il24 is reported between 25 and 35 kDa, a value higher than the deduced molecular weight of 23 kDa. This difference is likely due to post-translational modifications, such as glycosylation of the endogenously produced molecule when compared with recombinant Il24 controls (Wang et al., 2002) .
RP3 oncogene-induced expression of Il24 in vivo
Transgenic mice expressing human RP3 exclusively in the thyroid develop thyroid hyperplasia by 4 weeks of age and develop solid subtype papillary carcinomas as they age beyond 8 months of age (Powell et al., 1998) . Since analysis of Il24 expression was first identified from cell lines in vitro, we were interested in determining if RP3-induced genes were also found in the thyroids of RP3 transgenic mice. To investigate this, RT-PCR analysis was performed on freshly isolated thyroid tissue from RP3 transgenic mice. These data indicated that Il24 mRNA is expressed in the thyroid of RP3 The EtBrstained Il24 PCR products were quantified by densitometric analysis and the data from a total of six pools of cDNA are shown. Significant increases in Il24 expression was observed in RP3-expressing cells, but the expression was only partially induced in RP3
Y588F -expressing cells (*Po0.01). RP3 and RP3 Y588F mRNAs were expressed at similar levels since no statistical difference was found between them (P40.5). These data are obtained from six independent pools cDNA. (c) Vector control, RP3-or RP3 Y588F -expressing PC Cl3 thyroid cells were incubated in medium containing Brefeldin A for blocking secretion of cytokines before harvest. In all, 90 mg of total protein (cellular lysates) were resolved using 16% (b-actin) or 12% (Il24) SDS-PAGE gels, electroblotted onto nitrocellulose and hybridized with a polyclonal antiserum against b-actin and a polyclonal antiserum against rat Il24, respectively. Since rodent anti-Il24 antibody crossreacts with human Il24 protein, recombinant human Il24 was included as a positive control Figure 2 Thyroid-specific RP3 expression in transgenic mice induces Il24 mRNA. (a) Total RNA from thyroids of wild-type or RP3-expressing transgenic mice was reverse transcribed to produce cDNA, amplified by PCR using primers for the listed genes and PCR products resolved on a 2% agarose gel. Odd numbered lanes from 1 to 11 represent PCR products derived from individual pools of cDNA synthesized from wild-type mice, whereas even numbered lanes from 2 to 12 represent those from RP3-expressing mice. Lane 13 represents the negative control for these experiments (unrelated template). (b) Summary of pooled data shows induced expression of Il24 in RP3-expressing, but not control, mouse thyroid tissue. Il24 is expressed significantly higher in the thyroids of RP3-expressing transgenic mice than controls (*Po0.01). Data are derived from 14 mice/group RET/PTC3 oncoprotein induces Il24 S Shinohara and JL Rothstein transgenic mice but not in thyroid tissue from wild-type mice (Figure 2a and b) . Il24 mRNA expression was corroborated by analysis of protein expression using immunohistochemical methods. Indeed, serial sections of embedded mouse RP3-expressing thyroid organs stained brightly using a rodent-specific anti-Il24 antibody (Figure 3) . Specifically, the thyroids of the RP3 transgenic mice, which developed hyperplasia of the follicles including expanded colloid, produced Il24 protein within the cytoplasm of epithelial cells and also secreted this factor into the colloid, suggesting that large amounts of Il24 is locally released (Figure 3b) . No staining was detected in the colloid of RP3 transgenic thyroids treated with isotype control antibody (Figure 3c ). To verify the specificity of these reactions, we preabsorbed the Il24 antibody with purified recombinant Il24 protein prior to staining. This preabsorption step confirmed the specificity of antibody binding ( Figure 3d ) and indicated that Il24 reactivity was responsible for the staining observed in Figure 3b . Preabsorption with an unrelated recombinant protein failed to neutralize antibody reactivity (data not shown). The presence of inflammatory mediators within the follicle is consistent with the inflammatory nature of RP3-expressing tissue (Russell et al., 2003 (Russell et al., , 2004 . Indeed, luminal monocytes were present in transgenic specimens (Figure 3c and d) . Little to no background staining was observed in the colloid of anti-RET-stained wild-type thyroids (Figure 3e ) compared to the strong staining observed in positive control RP3 transgenic thyroids stained with anti-RET-specific antibody (Figure 3f ). Antibody specific for the RET kinase failed to bind thyroid tissue of wild-type mice but bound strongly to the thyroids of RP3 transgenics as seen in panel f. Luminal monocytes (arrows) were frequently found in RP3-expressing thyroids (c and d), a finding consistent with previous reports (Russell et al., 2004) . These images are representative of seven different thyroids specimens (magnification Â 40)
RET/PTC3 oncoprotein induces Il24 S Shinohara and JL Rothstein
Il24 supports the proliferation of RP3-expressing thyrocytes
Although several studies have demonstrated the proapoptotic effects of forced IL24 expression in malignant cells, less is known about its physiological function during neoplastic development. Ligand binding studies have shown that IL24 can initiate signaling through specific heterodimeric receptors belonging to the IL20R1/IL20R2 and IL22R1/IL20R2 gene families (Wang et al., 2002) . Expression of these receptors on thyroid cells would be a requisite if RP3-induced Il24 contributes to thyroid pathology. To investigate this possibility, we isolated RNA from mouse thyroids and examined Il24 receptor expression by RT-PCR. Results from these experiments showed that the common Il24 receptor chain Il20R2 was expressed equally in both wild-type and RP3 transgenic mice (Figure 4) . Even though the Il24 receptor was found on wild-type and RP3-expressing thyroid tissue, only thyroids expressing RP3 would likely support autocrine growth effects. Accordingly, we assessed the potential for Il24 to influence organ function through alterations in cell survival or by promoting cell death in RP3-expressing cells. To examine this, murine anti-Il24 antibody was incubated with RP3-expressing thyroid cells to neutralize the secreted Il24 in the culture medium. The proliferation of antibody-treated cells was compared with untreated RP3-expressing cells or antibody controltreated cells. Following a short-term (2 day) incubation period, we find that proliferation of anti-Il24-treated thyroid cells in culture is significantly reduced at all time points compared with the growth of cells in control cultures ( Figure 5 ).
Loss of Il24 expression from thyroid carcinomas of RP3
p53À/À mice correlates with the loss of RP3 expression
To better understand the inflammatory changes that occur in gene expression during later stages of tumor progression, we studied RP3 p53À/À mice that develop advanced thyroid malignancies containing regions of both differentiated and undifferentiated carcinoma (Powell et al., 2001) . These tumors were characterized as poorly differentiated carcinoma due to the presence of numerous mitotic figures, pleiotropic nuclear morphology and irregular cell shapes as described (Powell et al., 2001) . Since the loss of RP3 expression correlates with the loss of selected cytokine gene expression, we next examined if Il24 expression was also dependent on the presence of functional RP3 within tumors containing a mixed histological morphology. In differentiated regions of tumors, which expressed high amounts of RP3 protein (Figure 6a ), specific staining was also detected for Il24 (Figure 6b ). Interestingly, in undifferentiated regions of tumors expressing reduced or no RP3 protein (Figure 6c ), the presence of Il24 signal was likewise reduced (Figure 6d ).
Discussion
Thyroid epithelial cells are capable of producing a wide variety of inflammatory cytokines in larger quantities than any other endocrine cell type (Aust and Scherbaum, 1996) . Some of these, such as IL1, IL6, IL8 and For all experiments, cDNA was synthesized from the RNA of wild-type or RP3-expressing thyroids and amplified by PCR using gene-specific primers for the indicated genes. Lanes 1, 3 and 5 represent PCR products derived from individual wild-type mice, whereas lanes 2, 4 and 6 represent products derived from RP3-expressing mice. The product shown in lane 7 is from an unrelated mouse (negative control). (b) The relative mRNA expression of mouse Il20R2 is shown. There is no significant difference in the expression of RNA between wild-type and RP3-expressing thyroids (*P40.5). Data are derived from nine thyroid specimens Figure 5 Reduced proliferation of RP3-expressing thyroid cells by neutralizing anti-rat Il24. RP3-expressing cells were incubated with a 1 : 50 or 1 : 200 dilution of rat Il24-specific antisera or a 1 : 50 dilution of antisera directed against an unrelated recombinant protein. Shown is the ratio of the cell count before and after incubation with antisera at the indicated time points. Total cell numbers for anti-Il24 antibody-treated cultures were significantly lower at 24 and 48 h time points (*Po0.01). Error bars indicate s.e.m. from eight independent experiments RET/PTC3 oncoprotein induces Il24 S Shinohara and JL Rothstein TNFa can be induced even from normal thyroid cells, indicating that cytokines may not only contribute to various thyroid cancers but may also serve to support the homeostatic control of cell survival at precancerous stages (Rasmussen, 2000) . Tumor tissue or tumorderived cell lines from differentiated carcinomas release GCSF, GMCSF, IL1a, IL4, IL6, IL8, IL10, MCP1 and/ or TNFa (Tohyama et al., 1992; Kayser et al., 1995; Nakada et al., 1996; Basolo et al., 1998; Kurebayashi et al., 2000; Scarpino et al., 2000) and undifferentiated thyroid carcinomas produce GROa, GCSF, GMCSF, and IL1a, IL4, IL6, IL8, IL10, and/or TNFa (Enomoto et al., 1990; Yoshida et al., 1992; Aust and Scherbaum, 1996; Basolo et al., 1998; Stassi et al., 2003) , although, in either case, very little is known about when in tumor development these factors are made or what their purpose may be. Whereas no single biochemical pathway has been identified that explains factor production by thyroid cells, we previously demonstrated that an alternative form of activated RET kinase (RP3) can induce secretion of large amounts of Mcp1 and Gmcsf, a property dependent on the function of the tyrosine kinase domain (Russell et al., 2003) . In thyroid cells, some cytokines can act in an autocrine and/or paracrine manner in promoting the transformation of epithelial cells during tumorigenesis. For example, exposure to IL4 and IL10 reduces apoptosis and sensitivity of thyroid carcinomas to chemotherapeutic agents by inducing Bcl-2 and Bcl-XL (Stassi et al., 2003) . Using a similar approach, we showed that Il24 is induced by RP3 to support cell proliferation of RP3-expressing thyrocytes in an autocrine manner. Interestingly, since the receptor for Il24 was also found on normal thyrocytes, one consequence of Il24 production by transformed thyroid cells may be to influence neighboring nontransformed cells and, in this manner, contribute to a generalized growth-supporting effect in the thyroid likely causing aberrant epithelial cell growth. Consistent with these observations, rodent Il24 is implicated in the proliferation induced by oncogenic forms of RAS (Zhang et al., 2000) and is a critical growth factor for fibroblast-like cells at the wound edge during normal tissue repair (Soo et al., 1999) . In addition, over expression of Il24 in human colon carcinomas or in melanocytic nevi (Zhang et al., 2000; Ekmekcioglu et al., 2001) corresponds with the expression of oncogenic Ki-RAS or BRAF in these lesions (Zhang et al., 2000; Pollock et al., 2003) ; signaling pathways also implicated in the development of thyroid cancer (Kimura et al., 2003) .
In contrast to the findings of this study, direct gene delivery of human Il24 using recombinant adenoviruses caused cell death in malignant cells even though evidence of ligand-receptor binding was not demonstrated. In addition, the growth inhibition and apoptosis observed in a wide variety of human cancer cells was not observed in normal human cells (Su et al., 1998; Saeki et al., 2000; Ekmekcioglu et al., 2001; Lebedeva et al., 2003; Yacoub et al., 2003a) . In fact, when injected into animals, Il24 has been shown to reduce angiogenesis, an effect that appears to indirectly limit tumor progression (Saeki et al., 2000; Ramesh et al., 2003) . Thus, the apparent disparity of functions of Il24 may be explained either, in part, by species differences (Caudell et al., RET/PTC3 oncoprotein induces Il24 S Shinohara and JL Rothstein 2002) or by differences in the malignant nature of the target cell. Consistent with this, as cancer becomes more invasive (aggressive), genes expressed at early stages may be lost, suggesting a selection towards changing signaling pathways during cancer progression (Powell et al., 2001) . These data suggest that the growthpromoting effects of Il24 are stage specific and that the high levels of Il24 expression that may support the growth of differentiated thyroid malignancies may not be required for the continued proliferation and outgrowth of poorly differentiated (non-RP3-expressing) carcinomas. In summary, these studies provide a connection between the expression of cellular oncogenes and the production of inflammatory factors that influence the growth of newly transformed epithelial cells. Although the effects of Il24 have yet to be fully explored, these studies support the notion that oncogene-specific induction of Il24 is an important mediator of tumor cell survival and growth. The unusual abundance and frequency of Il24 in various differentiated thyroid carcinomas is offset by its apparent loss during tumor progression. Understanding this mechanism will be important for elucidating methods or therapeutic strategies to limit the spread of these, and other, malignancies.
Materials and methods
Mice
RP3 transgenic mice were generated as previously described (Powell et al., 1998) . RP3 mice were backcrossed to C3H/HeJ mice for greater than five generations. Homozygous RP3 mice on C3H/HeJ background mice were crossed to C57BL/6-Tpr53 mice (R Fishel, Kimmel Cancer Institute) and double heterozygous progeny intercrossed to generate RP3 p53À/À homozygotes.
Cell culture
PC CL3 rat thyrocytes were kindly provided by Dr Jeffery Knauf (University of Cincinnati, OH, USA). Vectors were individually transfected into PC CL3 cells. Briefly, the human RP3 oncogene was ligated into the retroviral vector, pMV7-Tyr588 (Tyr1062 of c-RET) in and the kinase domain was mutated to a phenylalanine by using QuickChange Mutagenesis Kit (Stratagene, La Jolla, CA, USA). The constructs, pMV7/RP3, pMV7/RP3 Y588F and the pMV7 vector alone were transfected into PC CL3 cells using the Phoenix transfection method supplied by the manufacturer. Following DNA transfer, cell transfectants were selected in thyroid cell growth media (Coon's modified F12 medium containing 5% FBS, 100 U/ml penicillin/streptomycin, 2 mM L-glutamine and the following growth factors: 10 ng/ml somatostatin, 10 ng/ml glycine-histidine-lysine, 5 mg/ml transferring, 10 nM hydrocortisone, 10 mg/ml insulin and 10 mIU/ml bovine thyroidstimulating hormone) supplemented with G418 (400 mg/ml). PC CL3 cells transfected with pMV7/RP3 were grown in separate medium without growth factors, since culture in this medium causes apoptosis and selects against newly expressing RP3 þ cells. Phoenix-Eco cells used for transfection were grown in Dulbecco's modified Eagle's media supplemented with 10% FBS and 100 U/ml penicillin/streptomycin.
RT-PCR analysis
Thyroid tissue, resected from transgenic or wild-type mice, was homogenized into 500 ml of TRIZOL (Invitrogen, Carlsbad, CA, USA). PC CL3 cells were homogenized in 1 ml of TRIZOL (Invitrogen, Carlsbad, CA, USA) according to protocols supplied by the manufacturer. RNA was extracted and purified and treated with RNAse-free DNAse (Ambion, Austin, TX, USA). DNA-free total RNA (5 mg) was converted into cDNA using Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA). The amount of template cDNA was estimated from the approximate 33% conversion rate of RNA to cDNA and amplified using primers specific to glyceraldehyde-3-phosphase dehydrogenase (G3pdh). The cycling parameters were chosen to provide linear estimations of products for comparison as described previously (Russell et al., 2003 (Russell et al., , 2004 . Each test cDNA was normalized to PCR products obtained with G3pdh primers and a ratio of products was reported. PCR cycling conditions consisted of one cycle of denaturation at 941C followed by 20-45 cycles of denaturation (941C for 30 s), primer annealing (601C for 30 s), extension (721C for 60 s) and a final single extension cycle of 721C for 7 min. PCR products were resolved in 2% agarose gels containing 0.5 mg/ml of EtBr and band intensities quantified using the BioRad Gel Doc system with an integrated densitometric analysis program. Optimal cycling conditions for each primer set to provide products in the linear portion of the amplification curve were determined by plotting cycle numbers varying from 20 to 45 cycles versus band intensities as described previously (Powell et al., 2003) . The optimal cycling conditions for G3pdh primer set was 25 cycles, while all other primer sets were determined to be 30 cycles. The following are specific sequences of primers for murine G3pdh, 5 0 primer GGGCCCCCTTCATTGACCTCAACTAC and 3 0 primer GGTACCATGACAAGCTTCCCATTCTC; rat Il24, 5 0 primer AGCTTGAGACAACAGATTCTCCCC and 3 0 primer ACTGTCACTAATGGGAAGCATGGC; mouse Il24, 5 0 primer GGACTACAGATTCTCCCCTGCCTG and 3 0 primer AGCATGGAATTGTCCTTACTGGGC; the human RP3 breakpoint region, 5 0 primer CCAGAGCAGAAGTCAGCA TCC and 3 0 primer CTCTTTCAGCATCTTCACGGC; and mouse Il20R2, 5 0 primer CTGCCCCTCAGAACCTCTCTG and 3 0 primer CCACAAGGAACTCAAACTGGG.
Western blotting
For detection of Il24, a soluble protein, we needed to block its secretion from the endoplasmic reticulum within target cells. To accomplish this, each transfected PC CL3 cell lines were incubated in medium containing 10 mg/ml of Brefeldin A for 5 h before harvest as described (Winterrowd and Chin, 1999) . After treatment, cells were homogenized in protein lysis buffer (20 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM EGTA 1% Triton X-100, 150 mM NaCl with freshly added 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride and 1 mM orthovanadate) and stored at À701C. Proteins were resolved using SDS-PAGE and gels transferred to a nitrocellulose membrane. Membranes were blocked for 60 min in TBST buffer (20 mM Tris-HCl (pH 7.6), 135 mM NaCl, 1% Tween-20) with 5% nonfat dry milk and immunoblotted with a 1 : 1000 dilution of rabbit anti-rat Il24 antisera (GenHunter Corp., Nashville, TN, USA) or with a 1 : 500 dilution of goat anti-human b actin (I-19) polyclonal antibody for 16 h at 41C. Anti-rat Il24 antisera was precleared using 4 mg/ml of protein from wild-type PC CL3 cells to reduce nonspecific binding. Following incubation, membranes were washed three times for 5 min in TBST buffer and treated with a 1 : 1000 dilution of horseradish peroxidase-conjugated donkey RET/PTC3 oncoprotein induces Il24 S Shinohara and JL Rothstein anti-rabbit IgG (Amersham) or a 1 : 5000 dilution of horseradish peroxidase-conjugated rabbit anti-goat IgG (Pierce Biotechnology, Rockford, IL, USA), respectively, for 2 h at RT. Membranes were washed again three times in TBST buffer and protein bands visualized using ECL (Amersham) after exposure to X-ray film for 10 min. Commercially available human Il24-His protein was used as a control for protein size and mobility (GenHunter Corp., Nashville, TN, USA).
Immunohistochemistry
Paraffin-embedded mouse thyroid sections were dewaxed with xylene and rehydrated in ethanol as described previously (Russell et al., 2000 (Russell et al., , 2003 (Russell et al., , 2004 . Slides were heated in 10 mM citrate buffer (pH 6.0) in a microwave for 15 min. Slides, cooled to RT, were washed with PBS and incubated in 3% H 2 O 2 /PBS for 10 min. Slides were then blocked with PBS/1% bovine serum albumin (BSA) containing 0.01% Tween-20 for 5 min, followed by10% normal serum for 15 min (goat serum was used for RET staining, whereas rabbit serum was used for Il24 staining). After blocking, specimens were incubated with a 1 : 200 dilution of a rabbit anti-human RET antibody (Santa Cruz Biologicals, Santa Cruz, CA, USA), specific for an epitope corresponding to the carboxy-terminal amino acids (784-801) of the RET/PTC protein or a 1 : 500 dilution of goat anti Il24 antibody (C-16, Santa Cruz Biologicals, Santa Cruz, CA, USA) overnight at RT. Control rabbit IgG (Vector Labs, Burlingame, CA, USA) and goat polyclonal IgG directed against an unrelated protein (human Bruton's tyrosine kinase) at the same dilution were also utilized for control staining. The next day, samples were washed with TBS three times, blocked with TBS/1% BSA þ 0.01% Tween-20 and incubated with biotinylated secondary antibody for 1 h at room temperature. Following this incubation, specimens were treated with substrate according to the DAB Vectastatin kit (Vector Labs, Burlingame, CA, USA), counterstained with hematoxylin, dehydrated and mounted.
Cell proliferation analysis
PC CL3 cells transfected with the pMV7/RP3 vector or control vectors were plated into each well of a 12-well tissue culture dish (5 Â 10 4 cells/well) using 500 ml of culture medium containing a 1 : 50 or 1 : 200 dilution of anti-rat Il24 rabbit antisera (GenHunter Corp., Nashville, TN, USA) or 1 : 50 dilution of rabbit antisera directed against an unrelated recombinant mouse protein. Then, at designated time points (0, 24 and 48 h) cells in each group were harvested by trypsinization and viable cells counted using trypan blue (GIBCO BRL, Grand Island, NY, USA).
Statistical analysis
Results are presented as the mean7s.e.m. The data were analysed using the Student's t-test with the Analyze-it add-in software program for Microsoft Excel. For these experiments P-values o0.05 were considered statistically significant.
